Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Antigenics raises $26.1 million

Antigenics (NASDAQ:AGEN) raised $26.1 million though a private placement of 8.7 million shares at $3,

Read the full 153 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE